Ziprasidone for system suitability 1
SIAL/Y0001272 - European Pharmacopoeia (EP) Reference Standard
Synonym: Ziprasidone hydrochloride monohydrate; 5-
CAS Number: 138982-67-9
Empirical Formula (Hill Notation): C21H21ClN4OS · HCl · H2O
Molecular Weight: 467.41
MDL Number: MFCD00921885
Linear Formula: C21H21ClN4OS · HCl · H2O
Product Type: Chemical
API family | ziprasidone |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C21H21ClN4OS.ClH.H2O/c |
InChI key | ZCBZSCBNOOIHFP-UHFFFAOYSA |
manufacturer/tradename | EDQM |
SMILES string | O.Cl.Clc1cc2NC(=O)Cc2cc1C |
storage temp. | 2-8°C |
Application: | Ziprasidone for system suitability 1 EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia. |
Biochem/physiol Actions: | Ziprasidone is an atypical antipsychotic; FDA approved for the treatment of schizophrenia. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
Symbol | GHS07,GHS08 |
Signal word | Warning |
Hazard statements | H317 - H373 |
Precautionary statements | P260 - P280 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |